121 related articles for article (PubMed ID: 34628270)
1. Curc-mPEG454, a PEGylated curcumin derivative, as a multi-target anti-fibrotic prodrug.
Xiao S; Deng Y; Shen N; Sun Y; Tang H; Hu P; Ren H; Peng M
Int Immunopharmacol; 2021 Dec; 101(Pt A):108166. PubMed ID: 34628270
[TBL] [Abstract][Full Text] [Related]
2. Curc-mPEG454, a PEGylated Curcumin Derivative, Improves Anti-inflammatory and Antioxidant Activities: a Comparative Study.
Cheng F; Chen Y; Zhan Z; Liu Y; Hu P; Ren H; Tang H; Peng M
Inflammation; 2018 Mar; 41(2):579-594. PubMed ID: 29234949
[TBL] [Abstract][Full Text] [Related]
3. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
[TBL] [Abstract][Full Text] [Related]
4. Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence.
Liu Z; Xiang H; Xiang D; Xiao S; Xiang H; Xiao J; Ren H; Hu P; Liu H; Peng M
Chin Med; 2022 Feb; 17(1):23. PubMed ID: 35180857
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of Nrf2/P62/Keap1 involves in the anti-fibrotic effect of combination of monoammonium glycyrrhizinate and cysteine hydrochloride induced by CCl
Chu S; Bi H; Li X; Cui L; He W; Tian Y; Liu F; Gao G; Wang Z; Chen N; Wang H
Eur J Pharmacol; 2021 Dec; 913():174628. PubMed ID: 34774851
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis.
Huang SS; Chen DZ; Wu H; Chen RC; Du SJ; Dong JJ; Liang G; Xu LM; Wang XD; Yang YP; Yu ZP; Feng WK; Chen YP
Eur J Pharmacol; 2016 May; 779():22-30. PubMed ID: 26945822
[TBL] [Abstract][Full Text] [Related]
7. Farnesoid X receptor activation is required for the anti-inflammatory and anti-oxidative stress effects of Alisol B 23-acetate in carbon tetrachloride-induced liver fibrosis in mice.
Zhang L; Lin W; Cai Y; Huang Z; Zhao R; Yan T; Xu H; Liu Z
Int Immunopharmacol; 2023 Oct; 123():110768. PubMed ID: 37573684
[TBL] [Abstract][Full Text] [Related]
8. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells.
Zhang F; Zhang Z; Chen L; Kong D; Zhang X; Lu C; Lu Y; Zheng S
J Cell Mol Med; 2014 Jul; 18(7):1392-406. PubMed ID: 24779927
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
He J; Bai K; Hong B; Zhang F; Zheng S
Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
[TBL] [Abstract][Full Text] [Related]
10. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.
Fu Y; Zheng S; Lin J; Ryerse J; Chen A
Mol Pharmacol; 2008 Feb; 73(2):399-409. PubMed ID: 18006644
[TBL] [Abstract][Full Text] [Related]
11. Curcumin and
Macías-Pérez JR; Vázquez-López BJ; Muñoz-Ortega MH; Aldaba-Muruato LR; Martínez-Hernández SL; Sánchez-Alemán E; Ventura-Juárez J
J Immunol Res; 2019; 2019():3019794. PubMed ID: 31183386
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
[TBL] [Abstract][Full Text] [Related]
13. Curcumin protects against liver fibrosis by attenuating infiltration of Gr1hi monocytes through inhibition of monocyte chemoattractant protein-1.
Huang R; Liu Y; Xiong Y; Wu H; Wang G; Sun Z; Chen J; Yan X; Pan Z; Xia J; Zhang Z; Wang J; Wu C
Discov Med; 2016 Jun; 21(118):447-57. PubMed ID: 27448781
[TBL] [Abstract][Full Text] [Related]
14. Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2.
Zakaria S; El-Sisi A
J Immunotoxicol; 2016 Jul; 13(4):453-62. PubMed ID: 26849241
[TBL] [Abstract][Full Text] [Related]
15. Curcumin reorganizes miRNA expression in a mouse model of liver fibrosis.
Hassan ZK; Al-Olayan EM
Asian Pac J Cancer Prev; 2012; 13(11):5405-8. PubMed ID: 23317191
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effects of Artemisia capillaris and Artemisia iwayomogi in a carbon tetrachloride-induced chronic hepatic fibrosis animal model.
Wang JH; Choi MK; Shin JW; Hwang SY; Son CG
J Ethnopharmacol; 2012 Mar; 140(1):179-85. PubMed ID: 22265746
[TBL] [Abstract][Full Text] [Related]
17. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro.
Zhang Z; Guo Y; Zhang S; Zhang Y; Wang Y; Ni W; Kong D; Chen W; Zheng S
Eur J Pharmacol; 2013 Dec; 721(1-3):133-40. PubMed ID: 24076327
[TBL] [Abstract][Full Text] [Related]
18. Acupuncture combined with curcumin disrupts platelet-derived growth factor β receptor/extracellular signal-regulated kinase signalling and stimulates extracellular matrix degradation in carbon tetrachloride-induced hepatic fibrosis in rats.
Zhang XP; Zhang F; Zhang ZL; Ma J; Kong DS; Ni GX; Wang AY; Chen WX; Lu Y; Zheng SZ
Acupunct Med; 2012 Dec; 30(4):324-30. PubMed ID: 22763371
[TBL] [Abstract][Full Text] [Related]
19. Curcumin protects against CCl4-induced liver fibrosis in rats by inhibiting HIF-1α through an ERK-dependent pathway.
Zhao Y; Ma X; Wang J; He X; Hu Y; Zhang P; Wang R; Li R; Gong M; Luo S; Xiao X
Molecules; 2014 Nov; 19(11):18767-80. PubMed ID: 25407718
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Curcuma longa L. extract on CCl
Lee GH; Lee HY; Choi MK; Chung HW; Kim SW; Chae HJ
BMC Res Notes; 2017 Feb; 10(1):77. PubMed ID: 28143589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
